CNS Pharmaceuticals, Inc. business relationships
Companies named in CNS Pharmaceuticals, Inc.’s 10-K filed 2026-03-31, and public companies whose annual reports name CNS Pharmaceuticals, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 3.5 / 10
- AI naming
- <1 / 100 Top 55% in its category
- Agent readiness
- 0 / 100
- AI adoption
- 0 / 100
Named in CNS Pharmaceuticals, Inc.’s annual report 1
“License Agreement with Cortice Biosciences, Inc. pursuant to which the Company obtained exclusive rights to certain intellectual property” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.